First Description of Colistin and Tigecycline-Resistant <i>Acinetobacter baumannii</i> Producing KPC-3 Carbapenemase in Portugal

First Description of Colistin and Tigecycline-Resistant <i>Acinetobacter baumannii</i> Producing KPC-3 Carbapenemase in Portugal

Herein, we describe a case report of carbapenem-resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i> isolates that were identified from the same patient at a Tertiary University Hospital Centre in Portugal. Antimicrobial susceptibility and the molecular c...

Full description

Bibliographic Details
Main Authors:	Cátia Caneiras, Filipa Calisto, Gabriela Jorge da Silva, Luis Lito, José Melo-Cristino, Aida Duarte
Format:	Article
Language:	English
Published:	MDPI AG 2018-11-01
Series:	Antibiotics
Subjects:	antimicrobial resistance Gram-negative bacteria <i>K. pneumoniae</i> <i>A. baumannii</i> KPC-3 carbapenemase colistin tigecycline
Online Access:	https://www.mdpi.com/2079-6382/7/4/96

Similar Items

Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
by: Jae-Min Park, et al.
Published: (2021-07-01)

Prevalence of Carbapenemases in Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates from the Kingdom of Bahrain
by: Nouf Al-Rashed, et al.
Published: (2023-07-01)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2021-07-01)

Multiple heteroresistance to tigecycline and colistin in Acinetobacter baumannii isolates and its implications for combined antibiotic treatment
by: Jeongwoo Jo, et al.
Published: (2023-06-01)

Colistin Dependency among Colistin-Heteroresistant <i>Acinetobacter baumannii</i> Isolates
by: Hadas Kon, et al.
Published: (2021-12-01)

Detection of kpc-type Carbapenemases in Clinical Isolates of Acinetobacter baumannii
by: Hannan Khodaei, et al.
Published: (2017-10-01)

Current Therapeutic Approaches for Multidrug-Resistant and Extensively Drug-Resistant <i>Acinetobacter baumannii</i> Infections
by: Petros Rafailidis, et al.
Published: (2024-03-01)

Characterization of Increased Extracellular Vesicle-Mediated Tigecycline Resistance in <i>Acinetobacter baumannii</i>
by: Hyejin Cho, et al.
Published: (2023-04-01)

Genetic Background of Carbapenem Resistant Acinetobacter baumannii in a Health Care Setting in Alexandria, Egypt
by: Amira Amine, et al.
Published: (2011-09-01)

Risk Factors Associated with Mortality in <i>Acinetobacter baumannii</i> Infections: Results of a Prospective Cohort Study in a Tertiary Public Hospital in Guayaquil, Ecuador
by: Luz Abarca-Coloma, et al.
Published: (2024-02-01)

Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infections: A Preliminary Study
by: Rujipas Sirijatuphat, et al.
Published: (2022-11-01)

Colistin Resistance in <i>Acinetobacter baumannii:</i> Molecular Mechanisms and Epidemiology
by: Katarina Novović, et al.
Published: (2023-03-01)

The Mechanism of Tigecycline Resistance in <i>Acinetobacter baumannii</i> Revealed by Proteomic and Genomic Analysis
by: Cunwei Liu, et al.
Published: (2023-05-01)

Quercetin: Synergistic Interaction with Antibiotics against Colistin-Resistant <i>Acinetobacter baumannii</i>
by: Elif Odabaş Köse, et al.
Published: (2023-04-01)

Two Distinct Genotypes of KPC-2-Producing <i>Klebsiella pneumoniae</i> Isolates from South Korea
by: Jee Hong Kim, et al.
Published: (2021-07-01)

Performance Evaluation of the VITEK2 and Sensititre Systems to Determine Colistin Resistance and MIC for <i>Acinetobacter baumannii</i>
by: Hae-Sun Chung, et al.
Published: (2022-06-01)

First Description of Ceftazidime/Avibactam Resistance in a ST13 KPC-70-Producing <i>Klebsiella pneumoniae</i> Strain from Portugal
by: Gabriel Mendes, et al.
Published: (2022-01-01)

Efficacy of Lysophosphatidylcholine as Direct Treatment in Combination with Colistin against <i>Acinetobacter baumannii</i> in Murine Severe Infections Models
by: Andrea Miró-Canturri, et al.
Published: (2021-02-01)

An Outbreak of <i>tet</i>(X6)-Carrying Tigecycline-Resistant <i>Acinetobacter baumannii</i> Isolates with a New Capsular Type at a Hospital in Taiwan
by: Yu-Chia Hsieh, et al.
Published: (2021-10-01)

Synergistic Antibacterial Effect of Casein-AgNPs Combined with Tigecycline against <i>Acinetobacter baumannii</i>
by: Yu-Hsuan Chen, et al.
Published: (2021-05-01)

Treatment of <it>Klebsiella Pneumoniae</it> Carbapenemase (KPC) infections: a review of published case series and case reports
by: Lee Grace C, et al.
Published: (2012-12-01)

iTRAQ-Based Differential Proteomic Analysis Reveals the Pathways Associated with Tigecycline Resistance in Acinetobacter baumannii
by: Ni Yang, et al.
Published: (2018-11-01)

Impact of Tigecycline’s MIC in the Outcome of Critically Ill Patients with Carbapenemase-Producing <i>Klebsiella pneumoniae</i> Bacteraemia Treated with Tigecycline Monotherapy—Validation of 2019′s EUCAST Proposed Breakpoint Changes
by: Matthaios Papadimitriou-Olivgeris, et al.
Published: (2020-11-01)

The Mechanism of Tigecycline Resistance in <i>Acinetobacter baumannii</i> under Sub-Minimal Inhibitory Concentrations of Tigecycline
by: Cunwei Liu, et al.
Published: (2024-02-01)

Fitness Costs of Tigecycline Resistance in <i>Acinetobacter baumannii</i> and the Resistance Mechanism Revealed by a Transposon Mutation Library
by: Ping Wang, et al.
Published: (2022-10-01)

Molecular Characteristics of Colistin Resistance in <i>Acinetobacter baumannii</i> and the Activity of Antimicrobial Combination Therapy in a Tertiary Care Medical Center in Lebanon
by: Antoine Abou Fayad, et al.
Published: (2024-02-01)

Colistin and Carbapenem-Resistant <i>Acinetobacter baumannii</i> Aci46 in Thailand: Genome Analysis and Antibiotic Resistance Profiling
by: Nalumon Thadtapong, et al.
Published: (2021-08-01)

Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant <i>Acinetobacter baumannii</i> Infection: A Meta-Analysis
by: Chienhsiu Huang, et al.
Published: (2022-06-01)

Carbapenemase-Producing Elizabethkingia Meningoseptica from Healthy Pigs Associated with Colistin Use in Spain
by: Pedro Miguela-Villoldo, et al.
Published: (2019-09-01)

Colistin Resistance Onset Strategies and Genomic Mosaicism in Clinical <i>Acinetobacter baumannii</i> Lineages
by: Viviana Cafiso, et al.
Published: (2021-11-01)

Clinical Efficacy and Nephrotoxicity of Colistin Alone versus Colistin Plus Vancomycin in Critically Ill Patients Infected with Carbapenem-Resistant <i>Acinetobacter baumannii</i>: A Propensity Score-Matched Analysis
by: Wasan Katip, et al.
Published: (2021-01-01)

Laboratory Surveillance of <i>Acinetobacter</i> spp. Bloodstream Infections in a Tertiary University Hospital during a 9-Year Period
by: Anastasia Spiliopoulou, et al.
Published: (2023-11-01)

Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible <i>Acinetobacter baumannii</i> VAP: Clinical, Pharmacokinetic and Microbiome Features
by: Gennaro De Pascale, et al.
Published: (2023-01-01)

Black Phosphorus-Based ZnO-Ag Nanocomposite for Antibacterial Activity against Tigecycline-Resistant <i>Acinetobacter baumannii</i>
by: Atanu Naskar, et al.
Published: (2023-10-01)

<i>Acinetobacter baumannii</i> under Acidic Conditions Induces Colistin Resistance through PmrAB Activation and Lipid A Modification
by: Seo-Yeon Ko, et al.
Published: (2023-04-01)

Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: insight from a pharmacovigilance study
by: Milo Gatti, et al.
Published: (2019-11-01)

Comparison between Colistin and Polymyxin B in the Treatment of Bloodstream Infections Caused by Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii-calcoaceticus Complex</i>
by: Rebeca Carvalho Lacerda Garcia, et al.
Published: (2023-08-01)

Optimization of Pyrazole Compounds as Antibiotic Adjuvants Active against Colistin- and Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Filomena Sannio, et al.
Published: (2022-12-01)

KPC-Producing <i>Enterobacterales</i> from Douro River, Portugal—Persistent Environmental Contamination by Putative Healthcare Settings
by: Josman Dantas Palmeira, et al.
Published: (2022-12-01)

Resistance mechanisms of tigecycline in Acinetobacter baumannii
by: Chunli Sun, et al.
Published: (2023-05-01)